Clinical studies have shown that titin antibody testing has a sensitivity of 69% and a specificity of 97% for thymic epithelial tumors, and Titin-Ab are detectable in approximately 70 to 90% of MG patients with thymoma (23, 24). This evidence concerns the gene TTN and thymic epithelial neoplasm.